Blood Pressure Measurement
Deviceautomated blood pressure measurement on 3 occasions at each consultation, twice with one month apart
NCT Number: NCT06523062
While a theoretical increase in systolic blood pressure (BP) of 10 mmHg can triple the relative risk of cardiovascular disease (CVD), the potential presence of a white coat effect (WCE) can interfere with the assessment of blood pressure control in the consultation. However, it is often difficult to assess the presence of a white coat effect (a quantitative variable) in general practice because of the difficulties in performing ambulatory BP measurements (self-measurement of blood pressure or ambulatory BP measurements). We have therefore previously described a surrogate concept of WCE obtained during a consultation with a general practitioner. It corresponds to a reduction of 10mmHg or more in systolic BP between the start and the end of the consultation. We have named it 'office white coat effect tail' (OWCET) and we have shown that OWCET, as a dichotomous variable, in a large Italian population cohort, with a follow-up of more than 18 years, was associated with an excess incidence of stroke, myocardial infarction (MI) and CVD and with excess mortality from MI and CVD. This concept appears to be more prevalent in women and is independent of blood pressure variability (regression to the mean). In addition, there is a genuine correlation between WCE and OWCET. To our knowledge, the reproducibility of the OWCET has never been studied, which could distort the relevance of this concept in the context of cardiovascular risk stratification in primary care.
Trial opening soon.
Get Notified18 year and older
All sexes
Interventional
Not applicable
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
automated blood pressure measurement on 3 occasions at each consultation, twice with one month apart
Time frame: 1 month
Measurement of OWCET on two occasions during two consultations separated by one month, using the same automated blood pressure monitor, in order to estimate an intraclass kappa coefficient (qualitative measurement).
Time frame: 1 month
Patients characteristics
Time frame: 1 month
Variation of OWCET definition in order to test OWCET reproducibility
Time frame: 1 month
To test impact of blood pressure variability
University Hospital, Caen
Other
Acronym: REBBRE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06960057
Ambulatory Blood Pressure Monitoring, Anxiety
Jacksonville, Florida, United States
View Trial DetailsNCT07086989
Aorta Stenosis, Aortic Coarctation
Budapest, Hungary
View Trial DetailsNCT03480217
Cardiovascular Diseases, Essential Hypertension
New York, United States
View Trial DetailsNCT05919420
Cardiovascular Diseases, Hypertension
View Trial Details